Rituximab and Omalizumab Combination Therapy for Bullous Pemphigoid
Stephanie T. Le, Samantha Herbert, Reneé Haughton, Jordan Nava, Atrin Toussi, Antonio Ji‐Xu, Emanual Maverakis
Abstract
This research letter reports on a case series of 10 patients with bullous pemphigoid treated with rituximab combined with omalizumab.
Topics & Concepts
MedicineOmalizumabBullous pemphigoidRituximabDermatologyMonoclonalImmunologyMonoclonal antibodyAntibodyImmunoglobulin EAutoimmune Bullous Skin DiseasesCoagulation, Bradykinin, Polyphosphates, and AngioedemaUrticaria and Related Conditions